VYNE Therapeutics Inc.
VYNE Therapeutics Inc., a biopharmaceutical company headquartered in the United States, is dedicated to developing innovative therapies for patients with unmet medical needs. Founded in 2017, VYNE focuses on dermatology and immunology, leveraging its proprietary drug delivery technologies to create unique formulations that enhance treatment efficacy. The company’s flagship product, Amzeeq, is a topical minocycline formulation that addresses acne vulgaris, showcasing VYNE's commitment to advancing patient care through novel solutions. With a strong market position, VYNE Therapeutics has achieved significant milestones, including successful product launches and strategic partnerships, solidifying its reputation as a leader in the biopharmaceutical industry.
DitchCarbon Score
How does VYNE Therapeutics Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
VYNE Therapeutics Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
VYNE Therapeutics Inc.'s reported carbon emissions
VYNE Therapeutics Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and commitments suggests that VYNE Therapeutics may not yet have established a formal framework for addressing its carbon footprint or climate impact. In the context of the pharmaceutical industry, many companies are increasingly adopting science-based targets and sustainability initiatives to mitigate their environmental impact. However, without specific commitments or data, it is unclear how VYNE Therapeutics aligns with these industry trends. As the company progresses, it may consider implementing strategies to measure and reduce its carbon emissions in line with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
VYNE Therapeutics Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
